Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Nov 16;7:e2300197. doi: 10.1200/PO.23.00197

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by American Society of Clinical Oncology

PMC Copyright notice

FIG 1. — (A) Continuous and categorical comparison of threshold-normalized DDIR score and status by HRD status within the S9313 TNBC cohort. For continuous comparison, P is Mann-Whitney; for categorical comparison, P is chi-square. (B) Continuous and categorial comparison of threshold normalized DDIR score and status by HRD status within the TCGA cohort. For continuous comparison P is Mann-Whitney; for categorical comparison P is chi-square. (C) Continuous and categorial comparison of threshold normalized DDIR score and status by tumor BRCA mutation status within the S9313 TNBC cohort. For continuous comparison P is Mann-Whitney; for categorical comparison P is chi-square. (D and E) Distribution of DDIR/HRD classes and threshold normalized DDIR and HRD scores within the (D) S9313 and (E) TCGA TNBC cohorts. r is Spearman's coefficient. DDIR, DNA damage immune response; HRD, homologous recombination deficiency; TCGA, The Cancer Genome Atlas; TNBC, triple-negative breast cancer.